M.D.C. (NYSE:MDC) Coverage Initiated at StockNews.com

Analysts at StockNews.com began coverage on shares of M.D.C. (NYSE:MDC) in a note issued to investors on Friday. The firm set a “hold” rating on the construction company’s stock.

MDC has been the topic of several other reports. Raymond James reissued a “market perform” rating on shares of M.D.C. in a research report on Wednesday, February 7th. Evercore ISI lowered M.D.C. from an “outperform” rating to an “in-line” rating and upped their price target for the company from $57.00 to $63.00 in a research report on Wednesday, January 31st. One analyst has rated the stock with a sell rating and five have given a hold rating to the stock. According to data from MarketBeat, M.D.C. presently has a consensus rating of “Hold” and a consensus price target of $52.13.

M.D.C. Stock Performance

M.D.C. stock opened at $62.98 on Friday. The stock has a market cap of $4.73 billion, a P/E ratio of 11.93 and a beta of 1.54. The company has a current ratio of 9.76, a quick ratio of 3.92 and a debt-to-equity ratio of 0.50. The stock has a 50 day moving average of $62.70 and a 200-day moving average of $53.60. M.D.C. has a 52 week low of $36.47 and a 52 week high of $63.00.

M.D.C. (NYSE:MDC) last released its earnings results on Tuesday, January 30th. The construction company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.50 by $0.06. The company had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.29 billion. M.D.C. had a return on equity of 12.32% and a net margin of 8.64%. The business’s revenue was down 11.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.08 EPS. On average, analysts expect that M.D.C. will post 5.7 EPS for the current fiscal year.

Insiders Place Their Bets

In other M.D.C. news, Director David E. Blackford sold 6,200 shares of the stock in a transaction on Monday, March 11th. The stock was sold at an average price of $62.69, for a total value of $388,678.00. Following the sale, the director now directly owns 13,534 shares of the company’s stock, valued at $848,446.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 23.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Sound Income Strategies LLC bought a new position in shares of M.D.C. in the fourth quarter worth $25,000. McGlone Suttner Wealth Management Inc. bought a new position in shares of M.D.C. in the fourth quarter worth $25,000. Ronald Blue Trust Inc. grew its stake in shares of M.D.C. by 100.0% in the third quarter. Ronald Blue Trust Inc. now owns 640 shares of the construction company’s stock worth $26,000 after purchasing an additional 320 shares in the last quarter. Clear Street Markets LLC bought a new position in shares of M.D.C. in the third quarter worth $29,000. Finally, GAMMA Investing LLC bought a new position in M.D.C. during the fourth quarter valued at about $34,000. Institutional investors own 88.08% of the company’s stock.

M.D.C. Company Profile

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.